Surveillance decision

Surveillance decision

We will not update the guideline on acute heart failure at this time.

Details are included in appendix A: summary of evidence from surveillance.

Reason for the decision

Assessing the evidence

We found 70 studies through surveillance of this guideline.

This included evidence that supports current recommendations on:

  • natriuretic peptide measurement

  • diuretic administration strategies

  • effectiveness of vasodilators

  • effectiveness of inotropes and vasodilators

  • other initial pharmacological treatments

  • ultrafiltration compared with diuretic therapy

  • other initial non-pharmacological treatments

  • use of beta blockers

  • use of angiotensin-converting enzyme (ACE) inhibitors

  • other treatments after stabilisation

  • percutaneous or surgical valvular interventions in people with mitral regurgitation.

Equalities

No equalities issues were identified during the surveillance process.

Overall decision

After considering all the evidence and views of topic experts and stakeholders, we decided that no update is necessary for this guideline.

See how we made the decision for further information.


This page was last updated: 14 December 2017